BioCryst Pharmaceuticals Inc (BCRX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -51.44 | -49.072 | -62.29 | -67.612 | -71.692 | -39.889 | -43.424 | -42.464 |
Return on Equity (%) | -223.699 | -154.155 | -152.256 | -248.944 | -1925.371 | 291.588 | 123.071 | 60.4 |
Return on Invested Capital (%) | -899.796 | -155.025 | -165.44 | -149 | -194.159 | -294.372 | 570.588 | 89.419 |
Operating Margin (%) | -184.636 | -227.178 | -445.824 | -198.638 | -944.942 | -77.951 | -53.647 | -35.602 |
Net Profit Margin (%) | -209.251 | -261.185 | -490.253 | -222.99 | -1026.353 | -117.11 | -91.245 | -68.356 |
Book Value Per Share | 0.021 | 0.851 | 0.447 | 0.248 | -0.109 | -0.58 | -1.568 | -2.224 |
Earnings Per Share | -0.747 | -0.668 | -0.92 | -0.707 | -1.034 | -0.998 | -1.315 | -1.106 |
Cash Per Share | 0.3 | 0.511 | 0.243 | 0.741 | 1.538 | 2.736 | 1.622 | 0.54 |
Working Capital Per Share | 0.171 | 0.514 | 0.408 | 0.467 | 1.233 | 2.508 | 2.187 | 1.689 |
Operating Profit Per Share | 0.333 | 0.251 | 0.188 | 0.293 | 0.092 | 0.818 | 1.415 | 1.604 |
EBIT Per Share | -0.747 | -0.668 | -0.92 | -0.707 | -1.034 | -0.986 | -1.301 | -1.105 |
EBITDA Per Share | -0.747 | -0.668 | -0.92 | -0.707 | -1.034 | -0.986 | -1.301 | -1.105 |
Free Cash Flow Per Share | -0.682 | -0.672 | -0.924 | -0.709 | -1.035 | -0.99 | -1.316 | -1.104 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 73,78M | 98,41M | 110,06M | 154,08M | 176,88M | 184,35M | 187,91M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 187,91M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -36.736 | N/A | N/A | N/A | -11.328 | N/A | N/A |
Net Profit Margin (%) | N/A | -77.544 | N/A | N/A | N/A | -38.14 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,55B |
Ratio cours/bénéfice | -6,69 |
Ratio prix/ventes | 4,58 |
Ratio prix/liquidités | 13,7 |
Ratio prix/valeur comptable | -3,33 |
Rendement de dividende | - |
Actions en circulation | 207,13M |
Volume moyen (1 semaine) | 1,73M |
Volume moyen (1 mois) | 1,8M |
Variation sur 52 semaines | 20,13% |
Plus haut sur 52 semaines | 8,88 |
Plus bas sur 52 semaines | 4,03 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales